Role of cyclin-dependent kinase inhibitor p57kip2 in the regulation of hematopoietic stem cell quiescence

被引：0
|
作者：
Yoshihara, Hiroki [1 ,2 ]
Zou, Peng [1 ]
Arai, Fumio [1 ]
Hosokawa, Kentaro [1 ]
Takubo, Keiyo [1 ]
Takahashi, Takao [2 ]
Suda, Toshio [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo, Japan
来源：
EXPERIMENTAL HEMATOLOGY | 2008年 / 36卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [1] Regulation of the cyclin-Dependent Kinase Inhibitor p57Kip2 Expression by p63
    Beretta, C
    Chiarelli, A
    Testoni, B
    Mantovani, R
    Guerrini, L
    [J]. CELL CYCLE, 2005, 4 (11) : 1625 - 1631
  • [2] the cyclin-dependent kinase inhibitor p57Kip2 mediates proliferative actions of PTHrP in chrondrocytes
    MacLean, HE
    Guo, J
    Knight, MC
    Zhang, PM
    Cobrinik, D
    Kronenberg, HM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09): : 1334 - 1343
  • [3] THE CYCLIN-DEPENDENT KINASE INHIBITOR p57kip2 IS A NEGATIVE REGULATOR OF SCHWANN CELL DIFFERENTIATION AND IN VITRO MYELINATION
    Heinen, A.
    Kremer, D.
    Goettle, P.
    Lehmann, H. C.
    Hartung, H. -P
    Kuery, P.
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2009, 14 : 64 - 64
  • [4] The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination
    Heinen, Andre
    Kremer, David
    Goettle, Peter
    Kruse, Fabian
    Hasse, Birgit
    Lehmann, Helmar
    Hartung, Hans Peter
    Kuery, Patrick
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (25) : 8748 - 8753
  • [5] Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen
    Watanabe, H.
    Pan, Z.-Q.
    Schreiber-Agus, N.
    DePinho, R. A.
    [J]. Proceedings of the National Academy of Sciences of the United States of America, 95 (04):
  • [6] Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen
    Watanabe, H
    Pan, ZQ
    Schreiber-Agus, N
    DePinho, RA
    Hurwitz, J
    Xiong, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) : 1392 - 1397
  • [7] The cyclin-dependent kinase inhibitor p57KIP2 functions as a tumor suppressor gene in human leukemia.
    Kuang, SQ
    Ling, XY
    Sanchez-Gonzalez, B
    Yang, H
    Garcia-Manero, G
    [J]. BLOOD, 2005, 106 (11) : 459A - 459A
  • [8] Downregulation of cyclin-dependent kinase inhibitor;: p57kip2, is involved in the cell cycle progression of vascular smooth muscle cells
    Nakano, N
    Urasawa, K
    Takagi, Y
    Saito, T
    Kaneta, S
    Ishikawa, S
    Higashi, H
    Tsutsui, H
    Hatakeyama, M
    Kitabatake, A
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (03) : 1661 - 1667
  • [9] C-Myb Controls Hematopoietic Stem Cell Quiescence and Differentiation Via Regulation of p57Kip2
    Cooke, Michael P.
    Sutton, Susan E.
    Parker, Albert E.
    [J]. BLOOD, 2010, 116 (21) : 1584 - 1584
  • [10] P21-Activated Kinase 4 Regulates the Cyclin-Dependent Kinase Inhibitor P57Kip2 in Human Breast Cancer
    Li, Yanshu
    Wang, Di
    Zhang, Hongyan
    Wang, Chunyu
    Dai, Wei
    Cheng, Zhenguo
    Wang, Guanqiao
    Li, Feng
    [J]. ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2013, 296 (10): : 1561 - 1567
12345